| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |